We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Stem Cells Predict Disease and Drug Toxicity

By HospiMedica staff writers
Posted on 24 Dec 2007
Scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease. More...


All-purpose stem cells elicited and identified the chemical signals secreted by the stem cells when exposed to a drug known to cause autism. The research shows that stem cells have an immediate clinical application as they generate chemicals, biomarkers that can be used to predict the onset of disease, much like cholesterol or sugar in the blood can be used to forecast heart disease or diabetes.

In a new study, a team led by University of Wisconsin-Madison, (UW-Madison; Madison, WI, USA) biologist Prof. Gabriela Cezar measured the response of undifferentiated stem cells as well as precursor neural cells to the drug valproate, which is known to cause autism in the offspring of a small percentage of users. The drug is used to treat epilepsy, bipolar disease, and migraine headaches. "We [are] measuring active metabolites produced by the cells in response to an insult,” explained Dr. Cezar, a professor of animal science. "These are de facto signatures of what is happening in response to a drug or a disease state.”

Cells of all kinds use small-molecule chemicals as a way to communicate with other cells. Precise communication between cells is essential for normal development and the health of an organism. Such chemicals can be detected in blood, suggesting that it may be possible to devise simple tests that can provide disease diagnosis before birth or shortly after. The ability to tune in to the chemical chatter of stem cells may become a promising new window to helping scientists figure out, at the most fundamental level, what goes wrong to cause things such as birth defects and miscarriage.

In addition, the study shows how human embryonic stem cells and early precursor cells can be used to screen drugs for potentially harmful effects. Drug discovery and testing had been predicted to be one of the first technologies to emerge from embryonic stem cells.

The study was reported in the December 2007 journal Stem Cells and Development.


Related Links:
University of Wisconsin-Madison

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.